These results from the main trial were supported by results from the overnight substudy in which a higher overall incidence of nocturnal hypoglycemia, measured by hourly plasma glucose, was found in the human insulin treatment arm (Kristensen et al., 2017). The gene discussed is INS; the disease is Hypoglycemia.